247
Views
18
CrossRef citations to date
0
Altmetric
Research Article

Limited utility of fluorescence in situ hybridization for common abnormalities of myelodysplastic syndrome at first presentation and follow-up of myeloid neoplasms

, , , , , & show all
Pages 601-605 | Received 11 Mar 2013, Accepted 27 Apr 2013, Published online: 28 Aug 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Drorit Merkel, Shelly Soffer, Iliya Novikov, Abraham Avigdor, Ninette Amariglio, Arnon Nagler & Luba Trakhtenbrot. (2019) Is fluorescence in-situ hybridization sufficient in patients with myelodysplastic syndromes and insufficient cytogenetic testing?. Leukemia & Lymphoma 60:3, pages 764-771.
Read now

Articles from other publishers (17)

Hadrian Mendoza & Alexa J. Siddon. (2023) Molecular Techniques and Gene Mutations in Myelodysplastic Syndromes. Clinics in Laboratory Medicine 43:4, pages 549-563.
Crossref
Eric J. Duncavage, Adam Bagg, Robert P. Hasserjian, Courtney D. DiNardo, Lucy A. Godley, Ilaria Iacobucci, Siddhartha Jaiswal, Luca Malcovati, Alessandro M. Vannucchi, Keyur P. Patel, Daniel A. Arber, Maria E. Arcila, Rafael Bejar, Nancy Berliner, Michael J. Borowitz, Susan Branford, Anna L. Brown, Catherine A. Cargo, Hartmut Döhner, Brunangelo Falini, Guillermo Garcia-Manero, Torsten Haferlach, Eva Hellström-Lindberg, Annette S. Kim, Jeffery M. Klco, Rami Komrokji, Mignon Lee-Cheun Loh, Sanam Loghavi, Charles G. Mullighan, Seishi Ogawa, Attilio Orazi, Elli Papaemmanuil, Andreas Reiter, David M. Ross, Michael Savona, Akiko Shimamura, Radek C. Skoda, Francesc Solé, Richard M. Stone, Ayalew Tefferi, Matthew J. Walter, David Wu, Benjamin L. Ebert & Mario Cazzola. (2022) Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia. Blood 140:21, pages 2228-2247.
Crossref
Harpreet Virk, Sonia Rana, Alpeshkumar B. Kapadia, Sreejesh Sreedharanunni, Nabhajit Mallik, Narender Kumar, Prashant Sharma, Shano Naseem, Man Updesh Singh Sachdeva, Jasmina Ahluwalia, Reena Das, Neelam Varma & Pankaj Malhotra. (2020) The utility of fluorescence in situ hybridization testing in patients clinically suspected of myelodysplastic syndrome or myelodysplastic syndrome/myeloproliferative neoplasm overlap is limited in the absence of significant morphological dysplasia. International Journal of Laboratory Hematology 42:6.
Crossref
Rose C BeckAnnette S KimRashmi S Goswami, Olga K Weinberg, Cecilia C S Yeung & Mark D Ewalt. (2020) Molecular/Cytogenetic Education for Hematopathology Fellows. American Journal of Clinical Pathology 154:2, pages 149-177.
Crossref
Alexa J Siddon & Robert P Hasserjian. (2020) How I Diagnose Low-Grade Myelodysplastic Syndromes. American Journal of Clinical Pathology 154:1, pages 5-14.
Crossref
Robert P Hasserjian, Todd W Kelley, Olga K Weinberg, Elizabeth A Morgan & Falko Fend. (2019) Genetic Testing in the Diagnosis and Biology of Myeloid Neoplasms (Excluding Acute Leukemias). American Journal of Clinical Pathology 152:3, pages 302-321.
Crossref
Ferrin C Wheeler, Annette S Kim, Claudio A Mosse, Aaron C Shaver, Ashwini Yenamandra & Adam C Seegmiller. (2018) Limited Utility of Fluorescence In Situ Hybridization for Recurrent Abnormalities in Acute Myeloid Leukemia at Diagnosis and Follow-up. American Journal of Clinical Pathology 149:5, pages 418-424.
Crossref
Sanam Loghavi & Robert P. Hasserjian. 2018. Diagnosis of Blood and Bone Marrow Disorders. Diagnosis of Blood and Bone Marrow Disorders 17 79 .
Tracy I. George, Joseph A. Tworek, Nicole E. Thomas, Lisa A. Fatheree, Rhona J. Souers, Raouf E. Nakhleh & Daniel A. Arber. (2017) Evaluation of Testing of Acute Leukemia Samples: Survey Result From the College of American Pathologists. Archives of Pathology & Laboratory Medicine 141:8, pages 1101-1106.
Crossref
Cynthia T Bunting, Tal Senior, Yehuda Susson, Alethia Rivera, Debra Saxe & Silvia T Bunting. (2017) Utility of Fluorescence In Situ Hybridization Panel for Myelodysplastic Syndrome in Evaluation of Cytopenia in a Pediatric Hospital: A 5-Year Retrospective Review and Utilization Management. Laboratory Medicine 48:3, pages 266-270.
Crossref
Annette S. Kim, Claudio A. Mosse, Aaron C. Shaver & Adam C. Seegmiller. 2017. Utilization Management in the Clinical Laboratory and Other Ancillary Services. Utilization Management in the Clinical Laboratory and Other Ancillary Services 189 202 .
Adam C. Seegmiller, Annette S. Kim, Claudio A. Mosse, , Aaron C. Shaver, Mary Ann Thompson, Shaoying Li, David R. Head & Mary M. Zutter. (2016) Data-Driven Iterative Refinement of Bone Marrow Testing Protocols Leads to Progressive Improvement in Cytogenetic and Molecular Test Utilization. American Journal of Clinical Pathology 146:5, pages 585-593.
Crossref
Rong He, Anne E. Wiktor, David K. Durnick, Paul J. Kurtin, Daniel L. Van Dyke, Ayalew Tefferi, Mrinal S. Patnaik, Rhett P. Ketterling & Curtis A. Hanson. (2016) Bone Marrow Conventional Karyotyping and Fluorescence In Situ Hybridization. American Journal of Clinical Pathology 146:1, pages 86-94.
Crossref
Jae Hyeon ParkMiyoung Kim, Sun-Young Kong, Sung-Soo Yoon & Dong Soon Lee. (2016) Monitoring of the Clonal Fraction by Fluorescence In Situ Hybridization in Myelodysplastic Syndrome: Comparison With International Working Group Treatment Response Criteria. Archives of Pathology & Laboratory Medicine 140:6, pages 560-569.
Crossref
Valentina Nardi & Robert P. Hasserjian. (2016) Genetic Testing in Acute Myeloid Leukemia and Myelodysplastic Syndromes. Surgical Pathology Clinics 9:1, pages 143-163.
Crossref
Kaaren K. Reichard & Adam J. Wood. (2016) Laboratory Test Utilization Management. Surgical Pathology Clinics 9:1, pages 1-10.
Crossref
Yue-Yun Lai, Xiao-Jun Huang, Juan Li, Ping Zou, Ze-Feng Xu, Hui Sun, Zong-Hong Shao, Dao-Bin Zhou, Fang-Ping Chen, Zhuo-Gang Liu, Huan-Ling Zhu, De-Pei Wu, Chun Wang, Yin Zhang, Yan Li, Ming Hou, Xin Du, Xin Wang, Wei Li, Yong-Rong Lai, Jin Zhou, Yu-Hong Zhou, Mei-Yun Fang, Lin Qiu, Xiao-Min Wang, Guang-Sen Zhang, Ming Jiang, Ying-Min Liang, Lian-Sheng Zhang, Xie-Qun Chen, Hai Bai & Jin-Ying Lin. (2015) Standardized fluorescence in situ hybridization testing based on an appropriate panel of probes more effectively identifies common cytogenetic abnormalities in myelodysplastic syndromes than conventional cytogenetic analysis: A multicenter prospective study of 2302 patients in China. Leukemia Research 39:5, pages 530-535.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.